Annual report pursuant to Section 13 and 15(d)

SHAREHOLDERS' EQUITY - Equity Compensation Plan Summary (Details)

v3.24.3
SHAREHOLDERS' EQUITY - Equity Compensation Plan Summary (Details) - 2014 and 2024 Equity Plan - USD ($)
$ / shares in Units, $ in Thousands
 12 Months Ended
Aug. 31, 2024
Aug. 31, 2023
Aug. 31, 2022
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]      
Outstanding, beginning of period (in shares) 563,000 712,500  
Granted (in shares) 0 0  
Exercised (in shares) (38,500) (119,500)  
Forfeited or expired (in shares) 0 (30,000)  
Outstanding, end of period (in shares) 524,500 563,000 712,500
Options exercisable (in shares) 465,500    
Outstanding, beginning of period (in dollars per share) $ 9.15 $ 8.75  
Granted (in dollars per share) 0 0  
Exercised (in dollars per share) 0 0  
Forfeited or expired (in dollars per share) 0 0  
Outstanding, end of period (in dollars per share) 9.42 $ 9.15 $ 8.75
Options exercisable (in dollars per share) $ 9.23    
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term 4 years 8 months 12 days 5 years 6 months 5 years 8 months 12 days
Weighted average remaining contractual term, options exercisable 4 years 6 months    
Approximate aggregate intrinsic value, outstanding $ 877 $ 1,221 $ 1,489
Approximate aggregate intrinsic value, options exercisable $ 820